PMID- 20465563 OWN - NLM STAT- MEDLINE DCOM- 20100816 LR - 20211020 IS - 1365-2567 (Electronic) IS - 0019-2805 (Print) IS - 0019-2805 (Linking) VI - 130 IP - 4 DP - 2010 Aug TI - Staphylococcal enterotoxin A induction of pro-inflammatory cytokines and lethality in mice is primarily dependent on MyD88. PG - 516-26 LID - 10.1111/j.1365-2567.2010.03249.x [doi] AB - Staphylococcal enterotoxin (SE) -induced toxic shock is triggered by inflammatory cytokine signal amplification after SE binding to major histocompatibility complex class II molecules on antigen-presenting cells and T-cell receptors. Identifying host cellular elements contributing to this pro-inflammatory signal amplification is critical for developing a strategy for therapeutic intervention. Myeloid differentiation primary-response protein 88 (MyD88) is an intracellular signalling adaptor protein primarily known for mediating pro-inflammatory cytokine responses. We investigated the role of MyD88 in staphylococcal enterotoxin A (SEA) -treated cell cultures and mouse models of toxic shock. Our results demonstrated that elevated levels of tumour necrosis factor-alpha, interferon-gamma, interleukin-1alpha/beta (IL-1alpha/beta), IL-2 and IL-6 production correlated with up-regulation of MyD88 after treatment of spleen cells and mice with SEA alone or in combination with lipopolysaccharide (LPS). The SEA-induced lethality was also observed in (LPS-independent) D-galactosamine-sensitized mice. While LPS potentiated SEA-induced cytokine responses, D-galactosamine treatment had no additive effect. Most importantly, our results demonstrated that MyD88(-/-) mice were resistant to SEA-induced toxic shock and had reduced pro-inflammatory cytokine responses. These results suggest that SEA-induced lethality is primarily dependent on MyD88. Our findings offer an important insight on potential therapeutic treatment of SEA-induced toxic shock targeting MyD88. FAU - Kissner, Teri L AU - Kissner TL AD - Department of Immunology, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA. FAU - Cisney, Emily D AU - Cisney ED FAU - Ulrich, Robert G AU - Ulrich RG FAU - Fernandez, Stefan AU - Fernandez S FAU - Saikh, Kamal U AU - Saikh KU LA - eng PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20100503 PL - England TA - Immunology JT - Immunology JID - 0374672 RN - 0 (Cytokines) RN - 0 (Enterotoxins) RN - 0 (Myd88 protein, mouse) RN - 0 (Myeloid Differentiation Factor 88) RN - 0 (NF-kappa B) RN - 37337-57-8 (enterotoxin A, Staphylococcal) SB - IM MH - Animals MH - Cells, Cultured MH - Cytokines/biosynthesis/*immunology MH - Enterotoxins/*toxicity MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Myeloid Differentiation Factor 88/deficiency/*immunology MH - NF-kappa B/immunology/metabolism MH - Spleen/immunology MH - Staphylococcus/drug effects/*immunology PMC - PMC2913262 EDAT- 2010/05/15 06:00 MHDA- 2010/08/17 06:00 PMCR- 2011/08/01 CRDT- 2010/05/15 06:00 PHST- 2010/05/15 06:00 [entrez] PHST- 2010/05/15 06:00 [pubmed] PHST- 2010/08/17 06:00 [medline] PHST- 2011/08/01 00:00 [pmc-release] AID - IMM3249 [pii] AID - 10.1111/j.1365-2567.2010.03249.x [doi] PST - ppublish SO - Immunology. 2010 Aug;130(4):516-26. doi: 10.1111/j.1365-2567.2010.03249.x. Epub 2010 May 3.